logo
Products
Technologies
Applications
Services
Resources
Selection Guides
About
PE/iFluor® 594 Anti-human CD58 Antibody
HI58a
HI58a is an anti-human monoclonal antibody that targets the CD58 antigen. CD58 (sometimes referred to as Lymphocyte function-associated antigen 3, LFA3 or LFA-3) is a 45 - 70 kD transmembrane protein that is located on the surface of cells such as macrophages, NK cells, dendritic cells, B cells and granulocytes. CD58 has been associated with key biological processes such as cell-cell adhesion, especially heterotypic cell-cell adhesion. Also, in certain organisms, it is involved in the positive regulation of interleukin-8 secretion. From a research standpoint, it is of biological interest due to its association with important macromolecules/ligands like CD2 and LFA-2. CD58 is a relatively rare antibody target, with less than 1000 publications in the last decade. Even still, CD58 is commonly used in flow cytometry applications as a phenotypic marker for differentiation of cell types, especially in the study of cell biology. This antibody was purified through affinity chromatography and conjugated to PE/iFluor® 594 (ex/em = 566/606 nm). It is compatible with the 561 nm laser and 589/15 nm bandpass filter (for example, as in the Bio-Rad ZE5 Cell Analyzer).
product image
product image
CatalogSize
Price
Quantity
105801Y025 tests
Price
105801Y1100 tests
Price
105801Y2500 tests
Price
 
Antibody properties

Other namesLFA-3
CloneHI58a
Hostmouse
Isotypemouse IgG1
Reactivityhuman
Spectral properties

Absorbance (nm)566
Extinction coefficient (cm -1 M -1)
1960000
Excitation (nm)565
Emission (nm)606
Storage, safety and handling

H-phraseH303, H313, H333
Hazard symbolXN
Intended useResearch Use Only (RUO)
R-phraseR20, R21, R22
Contact us

Telephone
Fax
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
Technical SupportContact us
Request quotationRequest
Purchase orderSend to sales@aatbio.com
ShippingStandard overnight for United States, inquire for international
Page updated on October 6, 2025